The latest news and top stories on Mirxes. A Singapore-headquartered entity in the biotechnology sector, Mirxes specialises in microRNA technology for early disease detection and precision medicine. It primarily serves global markets, particularly Asia, and is known for being Singapore’s first biotech unicorn and the first Southeast Asian biotech firm to list on the Hong Kong Stock Exchange.